WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 2 fonti

CEO of drugmaker GSK to step down by year's end

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.

Raccontata daapnews.comcnbc.com

Confronto fonti

2 prospettive sulla stessa storia
AI · summaries
apnews.comStai leggendo9 mesi fa

CEO of drugmaker GSK to step down by year's end

GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based drugmaker.

originale
cnbc.com9 mesi fa

GSK's Walmsley to step down early as insider Luke Miels named next CEO

GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on Monday.

Leggi questa versione → originale

Timeline cronologica

  1. lunedì 29 settembre 2025·apnews.com

    CEO of drugmaker GSK to step down by year's end

    GSK Chief Executive Emma Walmsley, the first woman to lead a major pharmaceutical company, will step down Dec. 31 after more than eight years at the head of the London-based…

  2. lunedì 29 settembre 2025·cnbc.com

    GSK's Walmsley to step down early as insider Luke Miels named next CEO

    GSK's CEO Emma Walmsley will step down in December and be replaced by insider Luke Miels, the British drugmaker said on Monday.